World / Science & Health Oct 19, 2017
DeepMind's superpowerful AI sets its sights on drug discovery
DeepMind, the London-based artificial intelligence company owned by Alphabet Inc., is planning to let its software learn how to fold proteins, an important problem for drug discovery. The company is best known for AlphaGo, software that beat the world's top human players at the ancient ...
